{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:24Z","timestamp":1794047424139,"version":"4.8.0"},"reference-count":37,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"7","license":[{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Donor clonal hematopoiesis may be transferred to the recipient through allogeneic hematopoietic stem cell transplantation (HSCT), but the potential for adverse long-term impact on transplant outcomes remains unknown. A total of 744 samples from 372 recipients who received HSCT and the corresponding donors were included. Bar-coded error-corrected sequencing using a modified molecular inversion probe capture protocol was performed, which targeted 33 genes covering mutations involved in clonal hematopoiesis with indeterminate potential (CHIP) and other acute myeloid leukemia-related mutations. A total of 30 mutations were detected from 25 donors (6.7%): the most frequently mutated gene was TET2 (n=7, 28%), followed by DNMT3A (n=4, 16%), SMC3 (n=3, 12%) and SF3B1 (n=3, 12%). With a median follow-up duration of 13 years among survivors, the presence of CHIP in the donor was not associated with recipient overall survival (P=0.969), relapse incidence (P=0.600) or non-relapse mortality (P=0.570). Donor CHIP did not impair neutrophil (P=0.460) or platelet (P=0.250) engraftment, the rates of acute (P=0.490), or chronic graft-versus-host disease (P=0.220). No significant difference was noted for secondary malignancy following HSCT between the two groups. The present study suggests that the presence of CHIP in allogeneic stem donors does not adversely affect transplant outcomes after HSCT. Accordingly, further study is warranted to reach a clearer conclusion on whether molecular profiling to determine the presence of CHIP mutations is necessary for the pretransplant evaluation of donors prior to stem cell donation.<\/jats:p>","DOI":"10.3324\/haematol.2022.281806","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T03:36:11Z","timestamp":1675308971000},"page":"1817-1826","source":"Crossref","is-referenced-by-count":18,"title":["Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up"],"prefix":"10.3324","volume":"108","author":[{"given":"Kyoung Ha","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TaeHyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Novitzky-Basso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngseok","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Sook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Pasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios V.","family":"Michelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Gerbitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Auro","family":"Viswabandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathali","family":"Kaushansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yardena","family":"Brilon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noa","family":"Chapal-Ilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Biezuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran I","family":"Shlush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Dong Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,2,2]]},"reference":[{"key":"49276","doi-asserted-by":"crossref","unstructured":"Jaiswal S, Fontanillas P, Flannick J. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014; 371(26):2488-2498.","DOI":"10.1056\/NEJMoa1408617"},{"key":"49277","doi-asserted-by":"crossref","unstructured":"Genovese G, Kahler AK, Handsaker RE. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014; 371(26):2477-2487.","DOI":"10.1056\/NEJMoa1409405"},{"key":"49278","doi-asserted-by":"crossref","unstructured":"Young AL, Challen GA, Birmann BM, Druley TE. Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults. Nat Commun. 2016; 7:12484.","DOI":"10.1038\/ncomms12484"},{"key":"49279","doi-asserted-by":"crossref","unstructured":"Abelson S, Collord G, Ng SWK. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. 2018; 559(7714):400-404.","DOI":"10.1038\/s41586-018-0317-6"},{"key":"49280","doi-asserted-by":"crossref","unstructured":"Rojek K, Nickels E, Neistadt B. Identifying inherited and acquired genetic factors involved in poor stem cell mobilization and donor-derived malignancy. Biol Blood Marrow Transplant. 2016; 22(11):2100-2103.","DOI":"10.1016\/j.bbmt.2016.08.002"},{"key":"49281","doi-asserted-by":"crossref","unstructured":"Gibson CJ, Kennedy JA, Nikiforow S. Donor-engrafted CHIP is common among stem cell transplant recipients with unexplained cytopenias. Blood. 2017; 130(1):91-94.","DOI":"10.1182\/blood-2017-01-764951"},{"key":"49282","doi-asserted-by":"crossref","unstructured":"Frick M, Chan W, Arends CM. Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation. J Clin Oncol. 2019; 37(5):375-385.","DOI":"10.1200\/JCO.2018.79.2184"},{"key":"49283","doi-asserted-by":"crossref","unstructured":"Oran B, Champlin RE, Wang F. Donor clonal hematopoiesis increases risk of acute graft versus host disease after matched sibling transplantation. Leukemia. 2022; 36(1):298.","DOI":"10.1038\/s41375-021-01430-y"},{"key":"49284","doi-asserted-by":"crossref","unstructured":"Coombs CC, Zehir A, Devlin SM. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 2017; 21(3):374-382.","DOI":"10.1016\/j.stem.2017.07.010"},{"key":"49285","doi-asserted-by":"crossref","unstructured":"Gupta V, Daly A, Lipton JH. Nonmyeloablative stem cell transplantation for myelodysplastic syndrome or acute. Biol Blood Marrow Transplant. 2005; 11(10):764-772.","DOI":"10.1016\/j.bbmt.2005.06.006"},{"key":"49286","doi-asserted-by":"crossref","unstructured":"Sibai H, Falcone U, Deotare U. Myeloablative versus reduced-intensity conditioning in patients with myeloid malignancies: a propensity score-matched analysis. Biol Blood Marrow Transplant. 2016; 22(12):2270-2275.","DOI":"10.1016\/j.bbmt.2016.08.030"},{"key":"49287","doi-asserted-by":"crossref","unstructured":"Khalil MMI, Messner HA, Lipton JH. Fludarabine and busulfan plus low-dose TBI as reduced intensity conditioning in. Ann Hematol. 2018; 97(10):1975-1985.","DOI":"10.1007\/s00277-018-3391-9"},{"key":"49288","doi-asserted-by":"crossref","unstructured":"Hiatt JB, Pritchard CC, Salipante SJ, O'Roak BJ, Shendure J. Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Res. 2013; 23(5):843-854.","DOI":"10.1101\/gr.147686.112"},{"key":"49289","doi-asserted-by":"crossref","unstructured":"Biezuner T, Brilon Y, Arye AB. An improved molecular inversion probe based targeted sequencing approach for low variant allele frequency. NAR Genom Bioinform. 2022; 4(1):lqab125.","DOI":"10.1093\/nargab\/lqab125"},{"key":"49290","unstructured":"Przepiorka D, Weisdorf D, Martin P. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant. 1995; 15(6):825-828."},{"key":"49291","doi-asserted-by":"crossref","unstructured":"Jagasia MH, Greinix HT, Arora M. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015; 21(3):389-401.","DOI":"10.1016\/j.bbmt.2014.12.001"},{"key":"49292","doi-asserted-by":"crossref","unstructured":"Michelis FV, Kotchetkov R, Grunwald RM. Long-term incidence of secondary malignancies after allogeneic hematopoietic cell transplantation: a single-center experience. Biol Blood Marrow Transplant. 2017; 23(6):945-951.","DOI":"10.1016\/j.bbmt.2017.02.015"},{"key":"49293","doi-asserted-by":"crossref","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013; 48(3):452-458.","DOI":"10.1038\/bmt.2012.244"},{"key":"49294","doi-asserted-by":"crossref","unstructured":"Boettcher S, Wilk CM, Singer J. Clonal hematopoiesis in donors and long-term survivors of related allogeneic hematopoietic stem cell transplantation. Blood. 2020; 135(18):1548-1559.","DOI":"10.1182\/blood.2019003079"},{"key":"49295","doi-asserted-by":"crossref","unstructured":"Fuster JJ, MacLauchlan S, Zuriaga MA. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science. 2017; 355(6327):842-847.","DOI":"10.1126\/science.aag1381"},{"key":"49296","doi-asserted-by":"crossref","unstructured":"Fuster JJ, Walsh K. somatic mutations and clonal hematopoiesis: unexpected potential new drivers of age-related cardiovascular disease. Circ Res. 2018; 122(3):523-532.","DOI":"10.1161\/CIRCRESAHA.117.312115"},{"key":"49297","doi-asserted-by":"crossref","unstructured":"Sano S, Oshima K, Wang Y. Tet2-mediated clonal hematopoiesis accelerates heart failure through a mechanism involving the IL-1beta\/NLRP3 inflammasome. J Am Coll Cardiol. 2018; 71(8):875-886.","DOI":"10.1016\/j.jacc.2017.12.037"},{"key":"49298","doi-asserted-by":"crossref","unstructured":"Savola P, Lundgren S, Keranen MAI. Clonal hematopoiesis in patients with rheumatoid arthritis. Blood Cancer J. 2018; 8(8):69.","DOI":"10.1038\/s41408-018-0107-2"},{"key":"49299","doi-asserted-by":"crossref","unstructured":"Nakata K, Gotoh H, Watanabe J. Augmented proliferation of human alveolar macrophages after allogeneic bone marrow transplantation. Blood. 1999; 93(2):667-673.","DOI":"10.1182\/blood.V93.2.667.402k25_667_673"},{"key":"49300","doi-asserted-by":"crossref","unstructured":"Eisenbarth SC. Dendritic cell subsets in T cell programming: location dictates function. Nat Rev Immunol. 2019; 19(2):89-103.","DOI":"10.1038\/s41577-018-0088-1"},{"key":"49301","doi-asserted-by":"crossref","unstructured":"Abegunde SO, Buckstein R, Wells RA, Rauh MJ. An inflammatory environment containing TNF\u03b1 favors Tet2-mutant clonal hematopoiesis. Exp Hematol. 2018; 59:60-65.","DOI":"10.1016\/j.exphem.2017.11.002"},{"key":"49302","doi-asserted-by":"crossref","unstructured":"Gibson CJ, Lindsley RC, Tchekmedyian V. Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma. J Clin Oncol. 2017; 35(14):1598-1605.","DOI":"10.1200\/JCO.2016.71.6712"},{"key":"49303","doi-asserted-by":"crossref","unstructured":"Ogawa S. Clonal hematopoiesis in acquired aplastic anemia. Blood. 2016; 128(3):337-347.","DOI":"10.1182\/blood-2016-01-636381"},{"key":"49304","doi-asserted-by":"crossref","unstructured":"Schoettler ML, Nathan DG. The pathophysiology of acquired aplastic anemia: current concepts revisited. Hematol Oncol Clin North Am. 2018; 32(4):581-594.","DOI":"10.1016\/j.hoc.2018.03.001"},{"key":"49305","doi-asserted-by":"crossref","unstructured":"Stanley N, Olson TS, Babushok DV. Recent advances in understanding clonal haematopoiesis in aplastic anaemia. Br J Haematol. 2017; 177(4):509-525.","DOI":"10.1111\/bjh.14510"},{"key":"49306","doi-asserted-by":"crossref","unstructured":"Fabre MA, Vassiliou GS. Home and away: clonal hematopoiesis in sibling transplants. Blood. 2020; 135(18):1511-1512.","DOI":"10.1182\/blood.2020005717"},{"key":"49307","doi-asserted-by":"crossref","unstructured":"Newell L, Williams T, Liu J. Engrafted donor-derived clonal hematopoiesis after allogenic hematopoietic cell. Transplant Cell Ther. 2021; 27(8):662.","DOI":"10.1016\/j.jtct.2021.04.014"},{"key":"49308","doi-asserted-by":"crossref","unstructured":"Gibson CJ, Kim HT, Zhao L. Donor clonal hematopoiesis and recipient outcomes after transplantation. J Clin Oncol. 2022; 40(2):189-201.","DOI":"10.1200\/JCO.21.02286"},{"key":"49309","doi-asserted-by":"crossref","unstructured":"Atsuta Y, Suzuki R, Yamashita T. Continuing increased risk of oral\/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol. 2014; 25(2):435-441.","DOI":"10.1093\/annonc\/mdt558"},{"key":"49310","doi-asserted-by":"crossref","unstructured":"DeZern AE, Gondek LP. Stem cell donors should be screened for CHIP. Blood Adv. 2020; 4(4):784-788.","DOI":"10.1182\/bloodadvances.2019000394"},{"key":"49311","doi-asserted-by":"crossref","unstructured":"Gibson CJ, Lindsley RC. Stem cell donors should not be screened for clonal hematopoiesis. Blood Adv. 2020; 4(4):789-792.","DOI":"10.1182\/bloodadvances.2019000395"},{"key":"49312","doi-asserted-by":"crossref","unstructured":"Randall J, Keven K, Atli T, Ustun C. Process of allogeneic hematopoietic cell transplantation decision making for older adults. Bone Marrow Transplant. 2016; 51(5):623-628.","DOI":"10.1038\/bmt.2015.241"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281806\/75320","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281806\/75747","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10964\/75320","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:03:27Z","timestamp":1794045807000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.281806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,2]]},"references-count":37,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.281806","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2,2]]}}}